SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-17-001508
Filing Date
2017-02-28
Accepted
2017-02-28 14:33:38
Documents
1
Group Members
CARIBOU THERAPEUTICS HOLDCO, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G caribou13g_dec312016.htm SC 13G 84812
  Complete submission text file 0001654954-17-001508.txt   86352
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filed by) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89486 | Film No.: 17646651
SIC: 2835 In Vitro & In Vivo Diagnostic Substances